stem cell Options
CALEC is patent-pending. Jurkunas and Dana have financial interest in OcuCell, an organization developing dwelling ophthalmic cell-based mostly therapies for managing eye ailment. Armant serves within the scientific advisory board for OcuCell.and its subsidiaries and affiliates (“STEMCELL”) to collect and use your info, and mail you newsletters